Related Experiment Video
Updated: Aug 27, 2025

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
RPRM negatively regulates ATM levels through its nuclear translocation on irradiation mediated by CDK4/6 and IPO11
Yarui Zhang1, Guomin Ou2, Zhujing Ye1
1State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University/Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, 199 Renai Road, Suzhou Industrial Park, Suzhou, Jiangsu Province 215123, P. R. China.
Abstract:
How the ataxia telangiectasia mutated (ATM) protein kinase, a core protein in DNA damage response, is regulated at post-transcription level remains unclear. Here it is identified that protein Reprimo (RPRM) downregulates ATM protein levels, resulting in impaired DNA repair and enhanced cellular radiosensitivity. Mechanistically, although primarily localized in the cytoplasm, RPRM translocates to the nucleus shortly after induced by X-irradiation, interacts with ATM and promotes its nuclear export and proteasomal degradation. The RPRM nuclear translocation involves its phosphorylation at serine 98 mediated by cyclin-dependent kinases 4/6 (CDK4/6), and requires Importin-11 (IPO11). Of importance, IPO11-regulated RPRM nuclear import upon irradiation is essential for its regulation on ATM. Thus, RPRM overexpression and its phosphorylation inhibition sensitize cells to genotoxic agents such as irradiation, whereas RPRM deficiency significantly increases resistance to radiation-induced damage both in vitro and in vivo. These findings establish a crucial regulatory mechanism in which ATM is negatively modulated by RPRM.
Insights
Protein Reprimo (RPRM) downregulates ataxia telangiectasia mutated (ATM) protein levels, impairing DNA repair and increasing radiosensitivity. RPRM nuclear import, regulated by Importin-11, is key to ATM degradation and cellular response to irradiation.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The post-transcriptional regulation of ataxia telangiectasia mutated (ATM) protein kinase, crucial for DNA damage response, is not fully understood.
- ATM protein kinase plays a central role in cellular responses to DNA damage, particularly double-strand breaks.
Purpose of the Study:
- To elucidate the post-transcriptional regulatory mechanisms of ATM protein kinase.
- To identify novel regulators of ATM protein levels and their impact on DNA repair and radiosensitivity.
Main Methods:
- Investigated the interaction between Reprimo (RPRM) and ATM protein kinase using cell-based assays.
- Utilized X-irradiation to induce DNA damage and observed RPRM translocation and ATM degradation.
- Employed techniques like Western blotting, immunofluorescence, and co-immunoprecipitation to study protein interactions and localization.
- Assessed cellular radiosensitivity and DNA repair capacity in cells with altered RPRM or Importin-11 (IPO11) expression.
Main Results:
- Protein Reprimo (RPRM) was identified as a negative regulator of ATM protein levels.
- RPRM translocates to the nucleus upon X-irradiation, interacts with ATM, and promotes its nuclear export and proteasomal degradation.
- RPRM nuclear import is mediated by Importin-11 (IPO11) and phosphorylation at serine 98 by CDK4/6.
- RPRM overexpression or IPO11 inhibition sensitizes cells to irradiation, while RPRM deficiency confers resistance to DNA damage.
Conclusions:
- RPRM negatively modulates ATM protein levels through a mechanism involving nuclear import, interaction with ATM, and subsequent degradation.
- The RPRM-ATM regulatory axis is critical for controlling cellular radiosensitivity and DNA repair efficiency.
- Targeting the RPRM-IPO11 pathway offers potential strategies for enhancing cancer therapy sensitivity to genotoxic agents.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Regulation of the Unfolded Protein Response
Abnormal Proliferation

